These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26668006)
1. Trimetazidine improves exercise tolerance in patients with ischemic heart disease : A meta-analysis. Zhao Y; Peng L; Luo Y; Li S; Zheng Z; Dong R; Zhu J; Liu J Herz; 2016 Sep; 41(6):514-22. PubMed ID: 26668006 [TBL] [Abstract][Full Text] [Related]
2. Effect of Trimetazidine on Diabetic Patients with Coronary Heart Diseases: A Meta-Analysis of Randomized, Controlled Trials. Lin Y; Wang ZL; Yan M; Zhu FY; Duan Y; Sun ZQ Chin Med Sci J; 2020 Sep; 35(3):226-238. PubMed ID: 32972500 [TBL] [Abstract][Full Text] [Related]
3. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. Zhang L; Lu Y; Jiang H; Zhang L; Sun A; Zou Y; Ge J J Am Coll Cardiol; 2012 Mar; 59(10):913-22. PubMed ID: 22381427 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy. Di Napoli P; Di Giovanni P; Gaeta MA; D'Apolito G; Barsotti A Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313 [TBL] [Abstract][Full Text] [Related]
5. Is treatment with trimetazidine beneficial in patients with chronic heart failure? Zhou X; Chen J PLoS One; 2014; 9(5):e94660. PubMed ID: 24797235 [TBL] [Abstract][Full Text] [Related]
6. Effect of trimetazidine on the functional capacity of ischemic heart disease patients not suitable for revascularization: Meta-analysis of randomized controlled trials. Ajabnoor A; Mukhtar A PLoS One; 2022; 17(2):e0263932. PubMed ID: 35148340 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials. Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study. Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of trimetazidine in non-ischemic heart failure patients: a meta-analysis of randomized controlled trials. Zhao C; Jin C; He X; Xiang M Rev Cardiovasc Med; 2021 Dec; 22(4):1451-1459. PubMed ID: 34957784 [TBL] [Abstract][Full Text] [Related]
10. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease. Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543 [TBL] [Abstract][Full Text] [Related]
11. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy]. Sisakian AS; Torgomian AL; Barkhudarian AL Klin Med (Mosk); 2006; 84(10):55-8. PubMed ID: 17201276 [TBL] [Abstract][Full Text] [Related]
12. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation. Belardinelli R; Lacalaprice F; Faccenda E; Volpe L Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405 [TBL] [Abstract][Full Text] [Related]
13. Effects of trimetazidine in nonischemic heart failure: a randomized study. Winter JL; Castro PF; Quintana JC; Altamirano R; Enriquez A; Verdejo HE; Jalil JE; Mellado R; Concepción R; Sepúlveda P; Rossel V; Sepúlveda L; Chiong M; García L; Lavandero S J Card Fail; 2014 Mar; 20(3):149-54. PubMed ID: 24412523 [TBL] [Abstract][Full Text] [Related]
14. Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: a preliminary study. Rogacka D; Guzik P; Wykretowicz A; Rzeźniczak J; Dziarmaga M; Wysocki H Coron Artery Dis; 2000 Mar; 11(2):171-7. PubMed ID: 10758819 [TBL] [Abstract][Full Text] [Related]
15. The role of metabolic therapy with trimetazidine in effort tolerance in patients with ischemic heart disease. Suljić U; Prnjavorac B; Bego T; Malenica M; Dujić T; Prnjavorac I; Čaušević A; Šaranović L Med Glas (Zenica); 2018 Aug; 15(2):109-114. PubMed ID: 30047538 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials. Marzilli M; Klein WW Coron Artery Dis; 2003 Apr; 14(2):171-9. PubMed ID: 12655281 [TBL] [Abstract][Full Text] [Related]
17. [Clinical-pharmacoeconomic aspects of trimetazidine modified release use in patients with ischemic heart disease undergoing coronary artery bypass grafting]. Lopatin IuM; Dronova EP Kardiologiia; 2009; 49(2):15-21. PubMed ID: 19254211 [TBL] [Abstract][Full Text] [Related]
18. The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy. Sisakian H; Torgomyan A; Barkhudaryan A Acta Cardiol; 2007 Oct; 62(5):493-9. PubMed ID: 17982971 [TBL] [Abstract][Full Text] [Related]
19. Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis. Zhang Y; Ma XJ; Shi DZ PLoS One; 2015; 10(9):e0137775. PubMed ID: 26367001 [TBL] [Abstract][Full Text] [Related]
20. Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial. Coats CJ; Pavlou M; Watkinson OT; Protonotarios A; Moss L; Hyland R; Rantell K; Pantazis AA; Tome M; McKenna WJ; Frenneaux MP; Omar R; Elliott PM JAMA Cardiol; 2019 Mar; 4(3):230-235. PubMed ID: 30725091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]